ALTERNATE-DAY PREDNISONE REDUCES MORBIDITY AND IMPROVES PULMONARY FUNCTION IN CYSTIC FIBROSIS
References (24)
- et al.
125I Clq-binding and specific antibodies as indicators of pulmonary disease activity in cystic fibrosis
J Pediatr
(1981) - et al.
Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5 year longitudinal study
J Pediatr
(1984) - et al.
Cystic fibrosis
Am Rev Respir Dis
(1976) - et al.
Proteins ofthe cystic fibrosis respiratory tract
J Clin Invest
(1984) - et al.
Immunologic aspects of cystic fibrosis
- et al.
Immune complexes in cystic fibrosis
Br Med J
(1975) - et al.
Immunological studies in cystic fibrosis
Arch Dis Child
(1978) - et al.
Hypogamma-globulinaemia in patients with cystic fibrosis
N Engl J Med
(1980) - et al.
A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine iontophoresis
Pediatrics
(1959) - et al.
A rapid plethysmographic method for measuring thoracic gas volume
J Clin Invest
(1956)
ATS statement: Snowbird workshop on standardization of spirometry
Am Rev Respir Dis
(1979)
Cited by (261)
Novel Immunomodulatory Therapies for Respiratory Pathologies
2022, Comprehensive PharmacologyStrong toll-like receptor responses in cystic fibrosis patients are associated with higher lung function
2020, Journal of Cystic FibrosisA specialized method of sputum collection and processing for therapeutic interventions in cystic fibrosis
2019, Journal of Cystic FibrosisCystic fibrosis
2019, Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics: Cardiovascular, Respiratory, and Gastrointestinal Disorders51 - Pulmonary Disease in Cystic Fibrosis
2019, Kendig's Disorders of the Respiratory Tract in ChildrenThe treatment of the pulmonary and extrapulmonary manifestations of cystic fibrosis
2017, Presse Medicale
Copyright © 1985 Published by Elsevier Ltd.